The EVERY Company, formerly known as Clara Foods, is a biotechnology firm specializing in the development of animal-free proteins for the food and beverage industry. Founded in 2014 and headquartered in South San Francisco, California, the company's mission is to accelerate the transition to sustainable, animal-free proteins, thereby reducing reliance on traditional animal agriculture. By leveraging precision fermentation technology, EVERY aims to produce proteins that are bioidentical to those found in animal products, offering sustainable alternatives without compromising on taste or functionality.
Key Strategic Focus
EVERY's strategic focus centers on the production of animal-free proteins through precision fermentation. The company specializes in creating bioidentical egg proteins, such as egg whites and pepsin, targeting the food and beverage sector. By utilizing yeast fermentation, EVERY converts sugar into proteins that mimic those traditionally sourced from animals. This approach not only addresses the growing consumer demand for sustainable and ethical food options but also offers functional ingredients suitable for various applications, including baking, nutrition, and pharmaceuticals.
Financials and Funding
Since its inception, EVERY has successfully secured significant funding to support its growth and innovation initiatives. In December 2021, the company closed a $175 million Series C financing round, positioning it to scale operations and expand its product offerings. Notable investors include AB InBev's innovation arm, ZX Ventures, which partnered with EVERY in April 2021 to scale production of its proprietary egg protein using fermentation processes akin to those in brewing. This partnership marked AB InBev's first collaboration with a food company, underscoring the strategic importance of EVERY's technology in the industry.
Pipeline Development
EVERY has developed a range of animal-free protein products, including:
- EVERY EggWhite: An animal-free egg white alternative suitable for baking and culinary applications.
- EVERY Pepsin: A bioidentical, animal-free pepsin enzyme used in pharmaceutical and food processing industries.
These products are designed to function identically to their animal-derived counterparts, offering sustainable and ethical alternatives without compromising on performance.
Technological Platform and Innovation
EVERY's proprietary technology revolves around precision fermentation, a process that uses yeast to convert sugar into specific proteins. This method allows for the production of bioidentical animal proteins without the need for animal agriculture. The company's innovative approach has led to the development of the world's first animal-free egg white, which foams, gels, and binds similarly to traditional egg whites, making it suitable for various culinary applications. Additionally, EVERY's animal-free pepsin offers a vegan alternative for industries that rely on this enzyme, such as pharmaceuticals.
Leadership Team
EVERY's leadership team comprises experienced professionals dedicated to advancing the company's mission:
- Arturo Elizondo: Co-Founder and CEO. Elizondo has been recognized for his contributions to biotechnology and sustainable food production, including being named in Forbes' "30 Under 30" list in 2020.
- Evan Geisert: Chief Financial Officer. Appointed in January 2025, Geisert brings extensive financial expertise to support EVERY's growth strategies.
- Konrad Mueller-Auffermann: Vice President of R&D and Technology Scale-Up. Joined in September 2023 to lead research and development initiatives.
Leadership Changes
Recent significant appointments include:
- Evan Geisert: Appointed as Chief Financial Officer in January 2025.
- Konrad Mueller-Auffermann: Joined as Vice President of R&D and Technology Scale-Up in September 2023.
Competitor Profile
Market Insights and Dynamics
The alternative protein market is experiencing rapid growth, driven by increasing consumer demand for sustainable and ethical food options. Advancements in biotechnology and fermentation processes have enabled companies like EVERY to develop animal-free proteins that meet these demands.
Competitor Analysis
Key competitors in the animal-free protein sector include:
- Perfeggt: A Berlin-based company founded in 2021, specializing in plant-based egg alternatives.
- Eat Just: Founded in 2011, Eat Just produces plant-based egg substitutes and cultivated meat products.
- Simply Eggless: Established in 2020, offering plant-based egg alternatives.
These companies focus on developing plant-based or cultivated alternatives to traditional animal products, contributing to the competitive landscape in the alternative protein industry.
Strategic Collaborations and Partnerships
EVERY has engaged in strategic partnerships to enhance its market position and innovation capacity:
- AB InBev Partnership: In April 2021, EVERY partnered with ZX Ventures, the innovation arm of AB InBev, to scale the production of its egg proteins using fermentation processes similar to brewing.
- Grupo Bimbo Investment: In 2019, Grupo Bimbo, the world's largest bakery, invested in EVERY, highlighting the strategic importance of animal-free proteins in the food industry.
Operational Insights
EVERY's competitive advantages include:
- Proprietary Precision Fermentation Technology: Enables the production of bioidentical animal proteins without animal agriculture.
- Strategic Partnerships: Collaborations with industry leaders like AB InBev and Grupo Bimbo enhance scalability and market reach.
- Sustainability Focus: Addresses consumer demand for ethical and sustainable food options.
Strategic Opportunities and Future Directions
EVERY is poised to capitalize on the growing demand for alternative proteins by:
- Expanding Product Portfolio: Developing new animal-free proteins to cater to diverse market needs.
- Scaling Production: Leveraging partnerships to increase production capacity and reduce costs.
- Entering New Markets: Exploring opportunities in international markets to broaden its customer base.
Contact Information
- Website: every.com
- LinkedIn: EVERY Company LinkedIn Profile
For further inquiries, please visit the company's official website.
